Dana-Farber Cancer Institute

Dana–Farber Cancer Institute is a comprehensive cancer treatment and research center in Boston, Massachusetts

A breakthrough in the treatment of telomere diseases

A new blood test detected more than 50 types of cancer as well as their location within the body

New tricks for many old drugs to kill cancer cells

A new blood test can detect multiple types of cancer

In study, test proved able to detect and localize more than 20 types of cancer with a high degree of accuracy Test detected methylation patterns associated with cancer in free-floating DNA in blood A new blood test in development has shown ability to screen for numerous types of cancer with a high degree of accuracy,

A new blood test can detect multiple types of cancer

Implanting a gel containing immunotherapy during surgical removal of a tumor may prevent the tumor from recurring

A new study by Dana-Farber Cancer Institute scientists suggests it may be possible to prevent tumors from recurring and to eradicate metastatic growths by implanting a gel containing immunotherapy during surgical removal of a tumor. In the study, published online today by Science Translational Medicine, researchers removed breast tumors from mice and placed biodegradable gels

Implanting a gel containing immunotherapy during surgical removal of a tumor may prevent the tumor from recurring

A personal cancer treatment vaccine for melanoma

A personal cancer treatment vaccine that targets distinctive “neoantigens” on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients, report scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. The study, published online by Nature “provides proof-of-principle that a personal vaccine tailored to a patient’s

A personal cancer treatment vaccine for melanoma

USC scientists open door for asthma cure

Study identifies molecule critical to asthma-causing cell’s survival Scientists led by molecular immunologists at the Keck School of Medicine of the University of Southern California (USC) have identified a way to target a recently discovered cell type that causes asthma, paving the way to cure the chronic respiratory disease that affects 25 million Americans. The

USC scientists open door for asthma cure

Promising results for Swedish cancer drug candidate

A new study conducted by scientists from the Dana-Farber Cancer Institute at Harvard Medical School and Karolinska Institutet presents very promising results for the treatment of the cancer form multiple myeloma. The drug candidate used in the research has been developed by scientists from Karolinska Institutet and a Swedish company following its initial identification at

Promising results for Swedish cancer drug candidate

Cross-Disciplinary Team From Harvard and Dana-Farber Brings Novel Therapeutic Cancer Vaccine to Human Clinical Trials

Designed to target skin cancer, the implantable vaccine opens a door to treating many cancers and inflammatory diseases A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer. The effort is the

Cross-Disciplinary Team From Harvard and Dana-Farber Brings Novel Therapeutic Cancer Vaccine to Human Clinical Trials

Solving Big-Data Bottleneck

Scientists team with business innovators to tackle research hurdles In a study that represents a potential cultural shift in how basic science research can be conducted, researchers from Harvard Medical School, Harvard Business School and London Business School have demonstrated that a crowdsourcing platform pioneered in the commercial sector can solve a complex biological problem

Solving Big-Data Bottleneck

A male contraceptive pill in the making?

“These findings suggest that a reversible, oral male contraceptive may be possible” The development of a male contraceptive pill has long proven to be elusive, but findings from a new study may point scientists in the right direction to making oral birth control for men a reality. Researchers at Dana-Farber Cancer Institute and Baylor College

A male contraceptive pill in the making?

First Targeted Nanomedicine to Enter Human Clinical Studies

BIND-014 is the first targeted and programmed nanomedicine to enter human clinical studies A team of scientists, engineers and physicians from Brigham and Women’s Hospital (BWH), Dana-Farber Cancer Institute (DFCI), Harvard Medical School (HMS), Massachusetts Institute of Technology (MIT), BIND Biosciences, Translational Genomics Research Institute (TGen), Wayne State University Karmanos Cancer Institute, and Weill Cornell

First Targeted Nanomedicine to Enter Human Clinical Studies

The Latest Bing News on:

Dana-Farber Cancer Institute Research

Niskayuna community eclipses fundraising goal for girl facing prospect of bone marrow transplant
The Niskayuna community has banded together to raise over $50,000 for a local 4-year-old girl who is facing the prospect of a bone marrow transplant.Erin Jasinski, 4, was diagnosed with Aplastic ...
Breast Cancer Survival Rates Have Steadily Improved for Women—But Not for Men
Over a similar period of time, breast cancer survival rates in women have substantially improved. Though breast cancer remains rare in men, the new study highlights the need for more research into ...
'My heart and soul': Berkley mom rides in PMC for daughter who lost battle with cancer
In the wake of unthinkable loss, one local mom is making it her mission to help cancer research. Kristina McGarry, of Berkley, will be pedaling in the 2023 Pan-Mass Challenge Winter Cycle on Feb. 4 in ...
Hillstream BioPharma Shares Double After Option Agreement With Dana-Farber Cancer Institute
By Chris Wack Hillstream BioPharma Inc. shares doubled to $1.34 after the company said it signed an exclusive option agreement with Dana-Farber ...
How Boston Is Beating Cancer
In November 2012, I had my bone marrow transplant at Boston Children’s Hospital. We found my donor, Andrew, through the national bone marrow registry, Be the Match. I got out of the hospital right ...

The Latest Bing News on:

Dana-Farber Cancer Institute Discovery

Hillstream BioPharma Shares Double After Option Agreement With Dana-Farber Cancer Institute
By Chris Wack Hillstream BioPharma Inc. shares doubled to $1.34 after the company said it signed an exclusive option agreement with Dana-Farber ...
Dana-Farber Cancer Institute discovers new KRAS G12D mutant inhibitors
Dana-Farber Cancer Institute Inc. has described small-molecule GTPase KRAS (G12D mutant) inhibitors reported to be useful for the treatment of cancer.
Immunotherapy with two novel drugs shows activity in colorectal cancer
Funding for this research comes from Agenus, Inc. Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment. Dana-Farber’s mission is to reduce the ...
Black and Hispanic cancer patients likely to receive less pain medications, Dana-Farber study says
Researchers at the Dana-Farber Cancer Institute found that older Black and Hispanic patients with advanced cancer are less likely to receive opioid medications for pain relief in the last weeks of ...
Molecular tumor board provides useful assist in cancer precision medicine
At Dana-Farber Cancer Institute, a multi-disciplinary team has been assisting gastrointestinal cancer physicians—reviewing test results and offering timely recommendations on treatment options.